Malaria thrives on administration in denial
a silent shift has been taking place in India's malaria profile. The malarial parasite Plasmodium vivax is no more the dominant cause of the disease. Plasmodium falciparum is taking over. This is common knowledge. Even the government knows. But what is not that clued into the public domain is the fact that vivax is relatively easier to treat and is less virulent -- meaning if you get vivax you are unlikely to cop it.
Falciparum is usually fatal. Especially when treatment regimes don't factor in the resistance falciparum acquires seamlessly. Unfortunately, the government does not react to the environment the way the parasite does. Falciparum reacts fast to new drugs. The only resistance the government develops is to new drug regimes. Being funded by the World Bank does not help, because the bank just follows the logic of the government. Moreover, because the bank follows the line of least resistance, new drugs get sidelined. The Indian government's focus is on vivax, so the bank is quite willing to go along with its priorities. Actually, the government does have an excuse. Not all falciparum in India is resistant to choloroquine and older drugs that have been used traditionally against the parasite. But drug resistance is a growing problem. So what is the extent of drug resistance in falciparum? The government hasn't bothered to find out enough to say for sure.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.